SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is trending as investors react to reports that activist investor Nelson Peltz's Trian Fund is preparing a take-private bid, sparking intense community discussion about a potential short squeeze. The stock is seeing massive trading volume and heightened volatility as traders weigh the likelihood of a buyout premium against the company's recent operational challenges.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is surging as investors react to a powerful Q2 earnings report featuring massive revenue growth and a bullish outlook on AI capacity pricing. The community is actively celebrating the stock's upward momentum, framing it as a direct defiance of prominent short sellers and fueling significant conversation around a potential short squeeze.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is surging following an impressive quarterly earnings report that highlighted a massive backlog and raised full-year revenue guidance, signaling robust demand for AI infrastructure despite significant capital expenditure. While the stock's sharp rally has triggered heavy trading volume and analyst upgrades, the community remains deeply divided, with bulls pointing to the company's long-term contract momentum while skeptics highlight concerns over aggressive debt levels and persistent cash burn.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

Marathon Digital is trending as shareholders vent intense frustration over the companys recent stock performance and leadership under CEO Fred Thiel. Community discourse is dominated by concerns over the lack of signed AI data center tenants, continuous insider selling, and significant volatility, leading many to compare the company unfavorably to its sector peers.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is surging following a blockbuster quarterly report that shattered earnings expectations, highlighted by record-breaking backlog orders and exceptionally strong forward guidance that signals massive AI infrastructure demand. The community is actively debating the stock's significant growth potential versus valuation concerns, with many investors anticipating a major short squeeze and a significant price re-rating as the company expands its enterprise market footprint.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending as investors await clarity on the AXPAXLI NDA submission timeline following a recent investor day and ongoing regulatory discussions. The community remains divided, with some betting on a transformative buyout or strong commercial adoption, while others express frustration over share price stagnation and ongoing dilution.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is surging following the announcement of positive Phase 2 clinical trial data for ABCL635, which demonstrated a significant reduction in the frequency and severity of menopausal hot flashes. The community is heavily focused on this clinical validation as a major de-risking event for the company's platform, with many investors actively debating the potential for a short squeeze given the substantial short interest and bullish price target upgrades from analysts.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is trending after announcing successful Phase 3 trial results for its depression treatment, DT120, which met primary and secondary endpoints. The community is actively discussing the stock's clinical foundation, upcoming trial readouts for anxiety, and the potential impact of a concurrent secondary equity offering on share price.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco is surging following a strong quarterly report where the company significantly raised its AI infrastructure order outlook, signaling its pivotal role in the enterprise networking supercycle. Investors are reacting positively to the combination of impressive hyperscaler demand and a strategic workforce restructuring aimed at reallocating resources toward high-growth AI and security initiatives.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum Holdings is trending as investors react to strong quarterly earnings that exceeded revenue and EPS expectations, driven by surging AI data center infrastructure demand. The community is actively discussing the stock's photonics sector positioning, the recent earnings beat, and its role as a key supplier for high-speed optical connectivity in the AI buildout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$QNTM looks interesting , could explode soon 
 
FDA cleared Lucid-MS to proceed into Phase 2—not drug approval. August 10 volume was 1.83M, roughly 10× its 20-day average, with about 13.4K Stocktwits watchers and indexed X discussion.  
 
Flagged by the Assassinator indicator few days ago 
 
https://www.tradingview.com/x/mUq4r6rW/

The_Assassin

Al915

TradingView

BATS:QNTM Chart Image by The_Assassin

StockTwits Web

Quantum BioPharma Ltd

 looks interesting , could explode soon 
 
FDA cleared Lucid-MS to proceed into Phase 2—not drug approval. August 10 volume was 1.83M, roughly 10× its 20-day average, with about 13.4K Stocktwits watchers and indexed X discussion.  
 
Flagged by the Assassinator indicator few days ago 
 
